Condition
Dementia With Lewy Bodies (DLB) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Dementia With Lewy Bodies (DLB) clinical trials that are recruiting, at sites in 4 countries (most in Sweden (2), United States (1), China (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Dementia With Lewy Bodies (DLB) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Natural history of atypical parkinsonian syndromes: a multi-center observation | — | Changshu, Jiangsu and 19 other locations | Recruiting | Sep 8, 2026 |
| Biomarker Repository for Age-Related and Inherited Neurodegenerative Diseases | — | Philadelphia, Pennsylvania | Recruiting | Sep 1, 2026 |
| Dementia with Lewy Bodies: Symptoms, Biomarkers and Progression | — | Stockholm | Recruiting | Jun 5, 2026 |
| Ultra-high-resolution PET imaging of aging, neurodegeneration, and psychotic disorders | — | Leuven, Vlaams-Brabant | Recruiting | Apr 3, 2026 |
| Testing a new PET tracer for measuring brain protein in neurodegenerative diseases | Early Phase 1 | Solna | Recruiting | Mar 24, 2025 |
All recruiting trials (5)
-
Natural history of atypical parkinsonian syndromes: a multi-center observation
This study follows people with APS like MSA, DLB, PSP, and CBD to see how their symptoms and brain images change over time.
-
Biomarker Repository for Age-Related and Inherited Neurodegenerative Diseases
This study collects blood and genetic samples from people with neurodegenerative diseases and their families to build a shared resource for studying disease risk and biology.
-
Dementia with Lewy Bodies: Symptoms, Biomarkers and Progression
This study tests how well clinical features, biological markers, and brain scans distinguish DLB and its early stages in patients seen at Stockholm clinics.
-
Ultra-high-resolution PET imaging of aging, neurodegeneration, and psychotic disorders
We will test whether ultra-high-resolution PET and 3T MRI scans can reveal early brain and spinal cord changes in healthy adults and people with Alzheimer's, Parkinson's disease, ALS, PSP, REM sleep behavior disorder, or psychotic disorders.
-
Testing a new PET tracer for measuring brain protein in neurodegenerative diseases
This study is testing a new imaging tool to see if it can help detect a specific brain protein in people with conditions like Parkinson's Disease and Dementia.
Related topics
Quick answers
How many Dementia With Lewy Bodies (DLB) clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Sweden (2 trials), United States (1 trial), China (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.